Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma
Paolo A. Ascierto, Reinhard Dummer, Helen J Gogas, Keith T. Flaherty, Ana Maria Arance, Mario Mandalà and 10 more
- Rank
- 16 of 947
- Percentile
- top 1.7%
- Where
- European Journal of Cancer, 2020
- Citations
- 181
From the 2020 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.